{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:22:45Z","timestamp":1792790565764,"version":"4.5.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T00:00:00Z","timestamp":1681948800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T00:00:00Z","timestamp":1681948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurol Belg"],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>To review clinical characteristics, auxiliary examination results, treatment effects, and outcomes of patients with autoimmune glial fibrillary acidic protein astrocytopathy (GFAP-A).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We collated and retrospectively analyzed clinical data of 15 patients admitted with clinical characteristics of an autoimmune GFAP-A acute encephalitis or meningitis phenotype.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>All patients were diagnosed with acute-onset meningoencephalitis and meningoencephalomyelitis. Initial presentations included pyrexia and headache at onset; dual symptoms of prominent tremor with urinary and bowel dysfunction; ataxia, psychiatric and behavioral abnormalities, and impaired consciousness; neck resistance; reduced extremity muscle strength; blurred vision; epileptic seizures; and reduced basic blood pressure. Cerebrospinal fluid (CSF) examination showed that the degree of protein elevation was significantly higher than the degree of increase in white blood cells. Moreover, in the absence of obvious low chloride and glucose levels, CSF chloride levels decreased in 13 patients, accompanied by a CSF glucose level decrease in four. Brain abnormalities were found in magnetic resonance imaging of ten patients, with a linear radial perivascular enhancement present in the lateral ventricles of two patients and symmetric abnormalities in the splenium of the corpus callosum in three patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Autoimmune GFAP-A may be a spectrum disorder, with acute- or subacute-onset meningitis, encephalitis, and myelitis being the main phenotypes. When used for acute stage treatment, combined hormone and immunoglobulin therapy was superior to hormone pulse therapy or immunoglobulin pulse therapy alone. However, hormone pulse therapy alone without immunoglobulin pulse therapy was associated with a greater number of remaining neurological deficits.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s13760-023-02268-0","type":"journal-article","created":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T19:33:54Z","timestamp":1682019234000},"page":"1465-1479","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Autoimmune glial fibrillary acidic protein astrocytopathy: clinical analysis and review of 15 cases"],"prefix":"10.1007","volume":"123","author":[{"given":"Wei","family":"Lan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6750-6717","authenticated-orcid":false,"given":"Jiming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiying","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiliang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,20]]},"reference":[{"issue":"11","key":"2268_CR1","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1001\/jamaneurol.2016.2549","volume":"73","author":"B Fang","year":"2016","unstructured":"Fang B et al (2016) Autoimmune glial fibrillary acidic protein astrocytopathy: a novel meningoencephalomyelitis. JAMA Neurol 73(11):1297\u20131307","journal-title":"JAMA Neurol"},{"issue":"6","key":"2268_CR2","first-page":"437","volume":"26","author":"J Huang","year":"2019","unstructured":"Huang J et al (2019) Research status of autoimmune glial fibrillar acidic protein astropathy. Chin J Neuroimmunol Neurol 26(6):437\u2013440","journal-title":"Chin J Neuroimmunol Neurol"},{"issue":"2","key":"2268_CR3","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/ana.24881","volume":"81","author":"EP Flanagan","year":"2017","unstructured":"Flanagan EP et al (2017) Glial fibrillary acidic protein immunoglobulin G as biomarker of autoimmune astrocytopathy: analysis of 102 patients. Ann Neurol 81(2):298\u2013309","journal-title":"Ann Neurol"},{"issue":"3","key":"2268_CR4","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/ene.13531","volume":"25","author":"Y Long","year":"2018","unstructured":"Long Y et al (2018) Autoimmune glial fibrillary acidic protein astrocytopathy in Chinese patients: a retrospective study. Eur J Neurol 25(3):477\u2013483","journal-title":"Eur J Neurol"},{"issue":"2","key":"2268_CR5","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1159\/000479948","volume":"24","author":"X Yang","year":"2017","unstructured":"Yang X et al (2017) Treatment of autoimmune glial fibrillary acidic protein astrocytopathy: follow-up in 7 cases. NeuroImmunoModulation 24(2):113\u2013119","journal-title":"NeuroImmunoModulation"},{"issue":"8","key":"2268_CR6","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1136\/jnnp.2003.034447","volume":"75","author":"F Graus","year":"2004","unstructured":"Graus F et al (2004) Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 75(8):1135\u20131140","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"2268_CR7","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1097\/WCO.0000000000000676","volume":"32","author":"A Kunchok","year":"2019","unstructured":"Kunchok A, Zekeridou A, McKeon A (2019) Autoimmune glial fibrillary acidic protein astrocytopathy. Curr Opin Neurol 32(3):452\u2013458","journal-title":"Curr Opin Neurol"},{"key":"2268_CR8","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3389\/fneur.2018.00251","volume":"9","author":"X Yang","year":"2018","unstructured":"Yang X et al (2018) Overlapping autoimmune syndromes in patients with glial fibrillary acidic protein antibodies. Front Neurol 9:251","journal-title":"Front Neurol"},{"key":"2268_CR9","doi-asserted-by":"publisher","first-page":"2802","DOI":"10.3389\/fimmu.2018.02802","volume":"9","author":"F Shan","year":"2018","unstructured":"Shan F, Long Y, Qiu W (2018) Autoimmune glial fibrillary acidic protein astrocytopathy: a review of the literature. Front Immunol 9:2802","journal-title":"Front Immunol"},{"issue":"4","key":"2268_CR10","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/s41380-018-0226-y","volume":"25","author":"F Petrelli","year":"2020","unstructured":"Petrelli F et al (2020) Dysfunction of homeostatic control of dopamine by astrocytes in the developing prefrontal cortex leads to cognitive impairments. Mol Psychiatry 25(4):732\u2013749","journal-title":"Mol Psychiatry"},{"key":"2268_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2020.577233","volume":"343","author":"P Paul","year":"2020","unstructured":"Paul P et al (2020) GFAP IgG associated inflammatory polyneuropathy. J Neuroimmunol 343:577233","journal-title":"J Neuroimmunol"},{"key":"2268_CR12","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.msard.2018.12.008","volume":"29","author":"C Francisco","year":"2019","unstructured":"Francisco C, Meddles K, Waubant E (2019) Pediatric glial fibrillary acidic protein meningoencephalomyelitis: a case report and review of the literature. Mult Scler Relat Disord 29:148\u2013152","journal-title":"Mult Scler Relat Disord"}],"container-title":["Acta Neurologica Belgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-023-02268-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13760-023-02268-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-023-02268-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T09:36:56Z","timestamp":1689154616000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13760-023-02268-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,20]]},"references-count":12,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["2268"],"URL":"https:\/\/doi.org\/10.1007\/s13760-023-02268-0","relation":{},"ISSN":["0300-9009","2240-2993"],"issn-type":[{"value":"0300-9009","type":"print"},{"value":"2240-2993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,20]]},"assertion":[{"value":"4 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Ethics Committee of Huizhou Central People\u2019s Hospital. All procedures performed in the studies that involved human participants complied with the ethical standards of the institutional or national research committee or both and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Data were handled in a manner that did not reveal the identity of any patients or control patients; therefore, formal consent (written or oral) for individuals was not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}